# A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102

> **NCT00048217** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Trimeris**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** T-1249

## Key facts

- **NCT ID:** NCT00048217
- **Lead sponsor:** Trimeris
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00048217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00048217, "A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00048217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*